Ventyx Biosciences IncNASDAQ:VTYX
- LAST PRICE4.0600
- TODAY'S CHANGE (%)-0.1800 (-4.2453%)
- Bid / Lots3.8800/ 6
- Ask / Lots4.2100/ 1
- Open / Previous Close4.1500 / 4.2400
- Day Range
- 52 Week Range
- Volume586,706
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VTYX |
|---|---|---|
| 09:32 ET | 4371 | 4.1198 |
| 09:34 ET | 3226 | 4.08 |
| 09:36 ET | 9656 | 4.06 |
| 09:38 ET | 2199 | 4.08 |
| 09:39 ET | 300 | 4.08 |
| 09:43 ET | 1050 | 4.09 |
| 09:45 ET | 1500 | 4.1062 |
| 09:48 ET | 4611 | 4.13 |
| 09:50 ET | 400 | 4.1461 |
| 09:54 ET | 543 | 4.12 |
| 09:56 ET | 5490 | 4.11 |
| 09:57 ET | 500 | 4.11 |
| 09:59 ET | 454 | 4.08 |
| 10:01 ET | 2860 | 4.095 |
| 10:03 ET | 4891 | 4.08 |
| 10:06 ET | 300 | 4.08 |
| 10:08 ET | 2991 | 4.08 |
| 10:10 ET | 2060 | 4.02 |
| 10:12 ET | 8124 | 4.0625 |
| 10:14 ET | 2250 | 4.085 |
| 10:15 ET | 700 | 4.1 |
| 10:17 ET | 1779 | 4.095 |
| 10:19 ET | 600 | 4.1 |
| 10:21 ET | 300 | 4.1 |
| 10:24 ET | 1113 | 4.09 |
| 10:26 ET | 400 | 4.085 |
| 10:28 ET | 2066 | 4.11 |
| 10:30 ET | 100 | 4.11 |
| 10:32 ET | 300 | 4.1 |
| 10:33 ET | 600 | 4.09 |
| 10:35 ET | 300 | 4.07 |
| 10:37 ET | 600 | 4.08 |
| 10:39 ET | 1500 | 4.08 |
| 10:42 ET | 1000 | 4.05 |
| 10:44 ET | 400 | 4.045 |
| 10:46 ET | 300 | 4.05 |
| 10:48 ET | 2986 | 4.07 |
| 10:50 ET | 1213 | 4.06 |
| 10:51 ET | 100 | 4.08 |
| 10:53 ET | 100 | 4.07 |
| 10:55 ET | 900 | 4.07 |
| 11:00 ET | 400 | 4.05 |
| 11:02 ET | 1556 | 4.06 |
| 11:04 ET | 200 | 4.055 |
| 11:06 ET | 300 | 4.05 |
| 11:08 ET | 200 | 4.04 |
| 11:09 ET | 6130 | 4.05 |
| 11:11 ET | 1300 | 4.05 |
| 11:13 ET | 408 | 4.05 |
| 11:15 ET | 979 | 4.05 |
| 11:20 ET | 1436 | 4.05 |
| 11:24 ET | 400 | 4.04 |
| 11:26 ET | 500 | 4.04 |
| 11:27 ET | 200 | 4.025 |
| 11:29 ET | 208 | 4.04 |
| 11:31 ET | 100 | 4.01 |
| 11:33 ET | 6455 | 4.005 |
| 11:36 ET | 400 | 3.99 |
| 11:38 ET | 300 | 3.995 |
| 11:40 ET | 2929 | 3.995 |
| 11:42 ET | 500 | 3.9925 |
| 11:44 ET | 700 | 4 |
| 11:45 ET | 200 | 4 |
| 11:47 ET | 1799 | 4.0089 |
| 11:49 ET | 170 | 4.005 |
| 11:51 ET | 1500 | 4.015 |
| 11:54 ET | 200 | 4.01 |
| 11:56 ET | 200 | 4.0005 |
| 11:58 ET | 300 | 4.01 |
| 12:00 ET | 1410 | 4.01 |
| 12:02 ET | 5497 | 4.01 |
| 12:03 ET | 400 | 4.02 |
| 12:05 ET | 1350 | 4.0002 |
| 12:07 ET | 1770 | 4.01 |
| 12:09 ET | 35429 | 3.99 |
| 12:12 ET | 400 | 3.98 |
| 12:14 ET | 824 | 3.98 |
| 12:16 ET | 2234 | 3.99 |
| 12:18 ET | 100 | 4 |
| 12:20 ET | 1300 | 3.985 |
| 12:21 ET | 2438 | 3.99 |
| 12:23 ET | 100 | 3.985 |
| 12:27 ET | 100 | 3.98 |
| 12:30 ET | 600 | 3.99 |
| 12:32 ET | 1652 | 3.995 |
| 12:34 ET | 2917 | 3.98 |
| 12:38 ET | 100 | 3.98 |
| 12:39 ET | 200 | 3.985 |
| 12:41 ET | 100 | 3.98 |
| 12:43 ET | 100 | 3.98 |
| 12:45 ET | 200 | 3.98 |
| 12:48 ET | 200 | 3.985 |
| 12:50 ET | 600 | 3.98 |
| 12:52 ET | 2588 | 3.9788 |
| 12:54 ET | 1300 | 3.96 |
| 12:56 ET | 7916 | 3.96 |
| 12:57 ET | 100 | 3.95 |
| 12:59 ET | 1354 | 3.95 |
| 01:03 ET | 3507 | 3.955 |
| 01:06 ET | 1400 | 3.96 |
| 01:08 ET | 2726 | 3.9512 |
| 01:10 ET | 5749 | 3.965 |
| 01:12 ET | 9959 | 3.9986 |
| 01:14 ET | 700 | 3.99 |
| 01:15 ET | 3221 | 4.0086 |
| 01:17 ET | 2375 | 4.0099 |
| 01:19 ET | 800 | 4.01 |
| 01:21 ET | 700 | 4.01 |
| 01:24 ET | 3563 | 3.98 |
| 01:26 ET | 500 | 3.97 |
| 01:28 ET | 1003 | 3.99 |
| 01:30 ET | 1299 | 4 |
| 01:32 ET | 900 | 4.015 |
| 01:33 ET | 1049 | 4.025 |
| 01:35 ET | 600 | 4.05 |
| 01:37 ET | 700 | 4.07 |
| 01:39 ET | 976 | 4.09 |
| 01:42 ET | 1463 | 4.08 |
| 01:44 ET | 1801 | 4.08 |
| 01:46 ET | 1570 | 4.1 |
| 01:48 ET | 2697 | 4.12 |
| 01:50 ET | 1160 | 4.12 |
| 01:51 ET | 1336 | 4.13 |
| 01:53 ET | 973 | 4.15 |
| 01:55 ET | 1332 | 4.1485 |
| 01:57 ET | 899 | 4.15 |
| 02:00 ET | 3368 | 4.13 |
| 02:02 ET | 100 | 4.12 |
| 02:04 ET | 3090 | 4.12 |
| 02:06 ET | 812 | 4.12 |
| 02:08 ET | 500 | 4.115 |
| 02:09 ET | 2284 | 4.12 |
| 02:11 ET | 671 | 4.12 |
| 02:13 ET | 550 | 4.12 |
| 02:15 ET | 800 | 4.115 |
| 02:18 ET | 8148 | 4.115 |
| 02:20 ET | 941 | 4.1 |
| 02:22 ET | 942 | 4.1 |
| 02:24 ET | 400 | 4.09 |
| 02:26 ET | 1903 | 4.085 |
| 02:27 ET | 2155 | 4.11 |
| 02:29 ET | 879 | 4.1 |
| 02:31 ET | 1063 | 4.11 |
| 02:33 ET | 1200 | 4.1 |
| 02:36 ET | 1100 | 4.1 |
| 02:38 ET | 500 | 4.11 |
| 02:40 ET | 1000 | 4.1 |
| 02:42 ET | 200 | 4.1 |
| 02:44 ET | 300 | 4.1 |
| 02:45 ET | 2681 | 4.095 |
| 02:47 ET | 7162 | 4.09 |
| 02:49 ET | 1000 | 4.095 |
| 02:51 ET | 1000 | 4.105 |
| 02:54 ET | 420 | 4.11 |
| 02:56 ET | 4318 | 4.09 |
| 02:58 ET | 100 | 4.08 |
| 03:00 ET | 1400 | 4.09 |
| 03:02 ET | 800 | 4.095 |
| 03:03 ET | 100 | 4.1 |
| 03:05 ET | 400 | 4.0925 |
| 03:07 ET | 300 | 4.1 |
| 03:09 ET | 1867 | 4.085 |
| 03:12 ET | 100 | 4.085 |
| 03:14 ET | 1237 | 4.09 |
| 03:16 ET | 1100 | 4.095 |
| 03:18 ET | 1100 | 4.1 |
| 03:20 ET | 700 | 4.11 |
| 03:21 ET | 6047 | 4.1084 |
| 03:23 ET | 4401 | 4.11 |
| 03:25 ET | 300 | 4.11 |
| 03:27 ET | 500 | 4.11 |
| 03:30 ET | 645 | 4.115 |
| 03:32 ET | 1800 | 4.12 |
| 03:34 ET | 700 | 4.115 |
| 03:36 ET | 550 | 4.115 |
| 03:38 ET | 605 | 4.11 |
| 03:39 ET | 4321 | 4.105 |
| 03:41 ET | 2388 | 4.11 |
| 03:43 ET | 2179 | 4.1 |
| 03:45 ET | 4983 | 4.09 |
| 03:48 ET | 2863 | 4.09 |
| 03:50 ET | 4841 | 4.08 |
| 03:52 ET | 5079 | 4.07 |
| 03:54 ET | 16826 | 4.09 |
| 03:56 ET | 14557 | 4.105 |
| 03:57 ET | 14081 | 4.085 |
| 03:59 ET | 108121 | 4.06 |
Today
Ventyx Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - VTYX, from 5 hours ago by Dow Jones
5 hours ago by Dow JonesApril 30, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against VTYX, from 5 hours ago by Dow Jones
5 hours ago by Dow JonesSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ventyx Biosciences, from 5 hours ago by Dow Jones
5 hours ago by Dow JonesGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ventyx Biosciences, Inc. (VTYX), from 6 hours ago by Dow Jones
6 hours ago by Dow JonesLevi & Korsinsky Reminds Ventyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 30, 2024 - VTYX, from 6 hours ago by Dow Jones
6 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ventyx Biosciences Inc | 298.6M | -1.2x | --- |
Nanobiotix SA | 279.1M | -3.3x | --- |
Nautilus Biotechnology Inc | 300.2M | -4.6x | --- |
Fractyl Health Inc | 301.2M | -3.4x | --- |
Acrivon Therapeutics Inc | 293.3M | -3.1x | --- |
Terns Pharmaceuticals Inc | 307.1M | -3.7x | --- |
Company Information
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with unmet need. The Company’s pipeline includes VTX002 (S1P1R Modulator), VTX958 (TYK2 Inhibitor), and VTX2735 and VTX3232 (NLRP3 Inhibitor Portfolio). VTX002 is a sphingosine 1 phosphate receptor (S1P1R) modulator in Phase II development for patients with moderately to severely active ulcerative colitis (UC). VTX958 is an oral, selective clinical-stage inhibitor of tyrosine kinase type 2 (TYK2), an intracellular signaling kinase in the Janus kinase (JAK) family that regulates chronic inflammation in immune-mediated diseases. Its third product candidate, VTX2735, is a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor. In addition to VTX2735, it is also developing VTX3232, its lead CNS-penetrant NLRP3 inhibitor in Phase 1 development.
Contact Information
- Headquarters
- 12790 El Camino Real, Suite 200SAN DIEGO, CA, United States 92130
- Phone
- 858-945-2393
- Fax
- 302-655-5049
Executives
- Executive Chairperson of the Board
- Sheila Gujrathi
- President, Chief Executive Officer, Founder, Director
- Raju Mohan
- Chief Financial Officer
- Martin Auster
- Chief Scientific Officer
- John Nuss
- Independent Director
- Onaiza Cadoret-manier
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $298.6M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.29 |
Book Value | $4.12 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
